Line 4: | Line 4: | ||
<head> | <head> | ||
<!-- Title for the page & metadata --> | <!-- Title for the page & metadata --> | ||
− | <title> | + | <title>part improvements</title> |
<meta charset="utf-8"> | <meta charset="utf-8"> | ||
Line 61: | Line 61: | ||
− | <h1> | + | <h1> Part Improvements </h1> |
<img src="https://static.igem.org/mediawiki/2017/e/e1/T--TECHNION-ISRAEL--improve_part.png" class="cover" alt="" style= "width:18% ; margin: auto;"> | <img src="https://static.igem.org/mediawiki/2017/e/e1/T--TECHNION-ISRAEL--improve_part.png" class="cover" alt="" style= "width:18% ; margin: auto;"> |
Revision as of 18:01, 30 October 2017
Part Improvements
We have improved two existing parts in an attempt to increase their utility to the iGEM community.
We improved the existing part (BBa_K1119008) - a device containing the GFP reporter gene under the CMV promoter with an hGH poly A terminator. By replacing the CMV promoter with TRE promoter (BBa_K2520006) we have created a convenient and important positive control for TRE based inducible systems.
Additionally, in our project we used the existing tTA transactivator part (BBa_K1061015) to test our Delay Mechanism. To use this basic part, we had to clone it into a mammalian expression vector, requiring time and effort.
In order to save future teams time, we have improved this part (BBa_K2520009) by adding a promoter (CMV) and a terminator (hGH poly A). Additionally, we tested this part and characterized it.
Name | Type | Description | Designer | Length | |||
---|---|---|---|---|---|---|---|
BBa_K2520006 | Device | TRE-GFP-hGH | Noa Eden, Dana Kadosh, Maya Engal, Shir Ovadia | 1532 | |||
BBa_K2520009 | Device | CMV-tTA-hGH | Noa Eden, Dana Kadosh, Maya Engal, Shir Ovadia | 1860 |